Manning-Geist BL, Gordhandas SB, Giri DD, Iasonos A, et al. Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer. Gynecol Oncol 2021 Nov 8. pii: S0090-8258(21)01551.
PMID: 34763937